Inventor · disambiguated record
Brett Granger
Also filed as: GRANGER BRETT
29 granted patents·2 pending applications·129 citations·filing 2016–2025
96Inventor score
Files withENANTA PHARM INC31
Top patents by PatentIndex Score
31 records- 0198US11560368B2Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereofENANTA PHARM INC·Filed 2021·Granted Jan 24, 2023·6 cites·18 claims
- 0298US10683279B2Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereofENANTA PHARM INC·Filed 2018·Granted Jun 16, 2020·13 cites·18 claims
- 0397US11420976B2Heterocyclic compounds as anti-viral agentsENANTA PHARM INC·Filed 2021·Granted Aug 23, 2022·7 cites·23 claims
- 0497US10988458B2Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereofENANTA PHARM INC·Filed 2020·Granted Apr 27, 2021·7 cites·23 claims
- 0595US10683289B2Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereofENANTA PHARM INC·Filed 2019·Granted Jun 16, 2020·10 cites·19 claims
- 0695US10676500B2Process for preparation of sulfonyl carbamate bile acid derivativesENANTA PHARM INC·Filed 2018·Granted Jun 9, 2020·7 cites·8 claims
- 0795US10450301B2Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereofENANTA PHARM INC·Filed 2018·Granted Oct 22, 2019·11 cites·20 claims
- 0895US10246439B2Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereofENANTA PHARM INC·Filed 2018·Granted Apr 2, 2019·12 cites·20 claims
- 0994US12018017B2Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereofENANTA PHARM INC·Filed 2022·Granted Jun 25, 2024·1 cites·14 claims
- 1094US11834436B2Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereofENANTA PHARM INC·Filed 2021·Granted Dec 5, 2023·2 cites·5 claims
- 1194US10253018B2Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereofENANTA PHARM INC·Filed 2018·Granted Apr 9, 2019·10 cites·26 claims
- 1291US10457703B2Bile acid derivatives as FXR/TGR5 agonists and methods of use thereofENANTA PHARM INC·Filed 2016·Granted Oct 29, 2019·8 cites·16 claims
- 1390US10597382B2Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereofENANTA PHARM INC·Filed 2018·Granted Mar 24, 2020·10 cites·17 claims
- 1489US11040998B2Bile acid derivatives as FXR/TGR5 agonists and methods of use thereofENANTA PHARM INC·Filed 2019·Granted Jun 22, 2021·2 cites·17 claims
- 1588US11958879B2Bile acid derivatives as FXR/TGR5 agonists and methods of use thereofENANTA PHARM INC·Filed 2021·Granted Apr 16, 2024·1 cites·5 claims
- 1688US10080743B2Isoxazole derivatives as FXR agonists and methods of use thereofENANTA PHARM INC·Filed 2017·Granted Sep 25, 2018·4 cites·22 claims
- 1787US10472386B2Bile acid derivatives as FXR agonists and methods of use thereofENANTA PHARM INC·Filed 2018·Granted Nov 12, 2019·6 cites·10 claims
- 1887US10080742B2Isoxazole derivatives as FXR agonists and methods of use thereofENANTA PHARM INC·Filed 2017·Granted Sep 25, 2018·3 cites·24 claims
- 1985US10149835B2Isoxazole derivatives as FXR agonists and methods of use thereofENANTA PHARM INC·Filed 2017·Granted Dec 11, 2018·2 cites·18 claims
- 2085US10080741B2Isoxazole derivatives as FXR agonists and methods of use thereofENANTA PHARM INC·Filed 2017·Granted Sep 25, 2018·3 cites·19 claims
- 2184US12459923B2Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereofENANTA PHARM INC·Filed 2023·Granted Nov 4, 2025·0 cites·12 claims
- 2281US11008304B2Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereofENANTA PHARM INC·Filed 2019·Granted May 18, 2021·1 cites·6 claims
- 2380US10144729B2Isoxazole analogs as FXR agonists and methods of use thereofENANTA PHARM INC·Filed 2017·Granted Dec 4, 2018·2 cites·20 claims
- 2480US2024327452A1Bile Acid Derivatives as FXR/TGR5 Agonists and Methods of Use ThereofENANTA PHARM INC·Filed 2024·Application pending·0 cites
- 2574US10138228B2Isoxazole derivatives as FXR agonists and methods of use therofENANTA PHARM INC·Filed 2017·Granted Nov 27, 2018·1 cites·18 claims
- 2671US12384753B217-beta-hydroxysteroid dehydrogenase type 13 inhibitors and methods of use thereofENANTA PHARM INC·Filed 2022·Granted Aug 12, 2025·0 cites·6 claims
- 2770US2025376452A117-Beta-Hydroxysteroid Dehydrogenase Type 13 Inhibitors and Methods of Use ThereofENANTA PHARM INC·Filed 2025·Application pending·0 cites
- 2866US10961272B2Process for preparation of sulfonyl carbamate bile acid derivativesENANTA PHARM INC·Filed 2020·Granted Mar 30, 2021·0 cites·12 claims
- 2952US11466033B2Substituted pyridines as apoptosis signal-regulating kinase 1 inhibitorsENANTA PHARM INC·Filed 2020·Granted Oct 11, 2022·0 cites·14 claims
- 3049US10968199B2Cycloalkyl-containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereofENANTA PHARM INC·Filed 2019·Granted Apr 6, 2021·0 cites·15 claims
- 3148US11345699B2Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereofENANTA PHARM INC·Filed 2019·Granted May 31, 2022·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Brett Granger files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →